Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel
…, F Starck Härlin, T Parkkari… - Proceedings of the …, 2015 - National Acad Sciences
Polyunsaturated fatty acids (PUFAs) affect cardiac excitability. Kv7.1 and the β-subunit
KCNE1 form the cardiac I Ks channel that is central for cardiac repolarization. In this study, we …
KCNE1 form the cardiac I Ks channel that is central for cardiac repolarization. In this study, we …
[HTML][HTML] An in-home advanced robotic system to manage elderly home-care patients' medications: A pilot safety and usability study
P Rantanen, T Parkkari, S Leikola, M Airaksinen… - Clinical …, 2017 - Elsevier
… Rantanen was Medical Head at Espoo City Hospital, and T. Parkkari is an employee of
Clinius Ltd., a contract research organization (CRO) that provides support and services for …
Clinius Ltd., a contract research organization (CRO) that provides support and services for …
Chiral 1, 3, 4-oxadiazol-2-ones as highly selective FAAH inhibitors
In the present study, identification of chiral 1,3,4-oxadiazol-2-ones as potent and selective
FAAH inhibitors has been described. The separated enantiomers showed clear differences in …
FAAH inhibitors has been described. The separated enantiomers showed clear differences in …
[PDF][PDF] Electrostatic tuning of cellular excitability
SI Börjesson, T Parkkari, S Hammarström, F Elinder - Biophysical journal, 2010 - cell.com
… sample t-test with the mean value compared to a hypothetical value of 0. For comparison of
shifts at different pH two-tailed unpaired t-test was used; p < 0.05 is considered as significant. …
shifts at different pH two-tailed unpaired t-test was used; p < 0.05 is considered as significant. …
[HTML][HTML] Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A)
JR Savinainen, JZ Patel, T Parkkari… - PLoS …, 2014 - journals.plos.org
Background Human lymphocyte antigen B-associated transcript 5 (BAT5, also known as
ABHD16A) is a poorly characterized 63 kDa protein belonging to the α/β-hydrolase domain (…
ABHD16A) is a poorly characterized 63 kDa protein belonging to the α/β-hydrolase domain (…
Loratadine analogues as MAGL inhibitors
…, T Laitinen, D Navia-Paldanius, T Parkkari… - Bioorganic & medicinal …, 2015 - Elsevier
Compound 12a (JZP-361) acted as a potent and reversible inhibitor of human recombinant
MAGL (hMAGL, IC 50 = 46 nM), and was found to have almost 150-fold higher selectivity …
MAGL (hMAGL, IC 50 = 46 nM), and was found to have almost 150-fold higher selectivity …
New quinolone-and 1, 8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno–modulatory activity
C Manera, AM Malfitano, T Parkkari, V Lucchesi… - European Journal of …, 2015 - Elsevier
… process in MS, thus in order to address potential different effects between cells derived
from patients and healthy controls, we evaluated the efficacy of our compounds on some T cell …
from patients and healthy controls, we evaluated the efficacy of our compounds on some T cell …
Synthesis, in vitro and in vivo evaluation of 1, 3, 5-triazines as cannabinoid CB2 receptor agonists
…, O Keinänen, A Poso, TJ Nevalainen, T Parkkari - European Journal of …, 2015 - Elsevier
… Comparison between IC 50 mean values was obtained by the Student’s t test analysis for …
Comparison between IC 50 mean values was obtained by the Student’s t test analysis for …
Comparison between IC 50 mean values was obtained by the Student’s t test analysis for …
[HTML][HTML] Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease
T Heikkinen, T Bragge, N Bhattarai, T Parkkari… - Plos one, 2020 - journals.plos.org
Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by
severe disruption of cognitive and motor functions, including changes in posture and gait. A …
severe disruption of cognitive and motor functions, including changes in posture and gait. A …
Optimization of 1, 2, 5‐thiadiazole carbamates as potent and selective ABHD6 inhibitors
…, AS Haka, FR Maxfield, JT Laitinen, T Parkkari - …, 2015 - Wiley Online Library
At present, inhibitors of α/β‐hydrolase domain 6 (ABHD6) are viewed as a promising approach
to treat inflammation and metabolic disorders. This article describes the development of 1,…
to treat inflammation and metabolic disorders. This article describes the development of 1,…